Intellia Therapeutics (NTLA) Q3 2026 Earnings

30JulConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
-1.02
-0.95
-0.87
-0.8

Details

Expected EPS
-0.801662
Actual EPS
N/A
Surprise EPS
0.8
Surprise Percent
+100%

Description

Intellia Therapeutics (NTLA) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts